The loan is to be granted by lender Banca Transilvania (TLV.RO), the report reads.
Shareholders will also discuss “reducing the multi-currency/multi-purpose financing line opened at UniCredit Bank SA from RON55 million to RON15 million and guaranteeing it with a movable mortgage on all accounts and sub-accounts, opened or to be opened by Antibiotice SA at the UniCredit Bank SA. The approval for authorizing the General Director, Mr. Ioan NANI, to sign on behalf of the company all the documents necessary to fulfill the previously mentioned purposes or any other subsequent documents,” the report also shows.
ATB shares have gained 247.4% in the last 12 months, due to improved financial results in 2023.
Antibiotice is 53%-owned by the Romanian State, through the Health Ministry, and 29.4% by Infinity Capital Investments.